Literature DB >> 9143002

Immunohistochemical expression of retinoid X receptor isoforms in human pituitaries and pituitary adenomas.

N Sanno1, A Sugawara, A Teramoto, Y Abe, P M Yen, W W Chin, R Y Osamura.   

Abstract

Retinoid X receptors (RXRs) are transcriptional factors that belong to the steroid/thyroid hormone receptor superfamily. There are 3 RXR isoforms-alpha, beta, gamma-known to bind 9-cis-retinoic acid as their ligand. The expression of RXRs in human pituitary glands and pituitary adenomas has not been extensively investigated. To determine whether specific RXR isoforms may play roles in the state of differentiation of pituitary adenomas, we have investigated the immunohistochemical expression of RXR alpha and RXR gamma in 6 nontumorous pituitaries and in 60 different pituitary adenomas using isoform-specific antibodies. In the nontumorous pituitaries. RXR alpha was expressed in the nuclei of almost all cells, while RXR gamma was only expressed in thyrotropin (TSH) cells and in some cells positive for growth hormone (GH) and glycoprotein alpha-subunit (alpha SU) but not in luteinizing hormone (LH) beta-subunit, follicle-stimulating hormone (FSH) beta-subunit, prolactin (PRL) or adrenocorticotropin (ACTH) cells by double immunostaining. All 60 adenomas were RXR alpha positive, and 39 of 60 adenomas (65%) were positive for RXR gamma. The incidence of RXR gamma immunoreactivity in the different adenoma types was: 13 of 16 GH-producing adenomas (81.3%), 9 of 14 PRL-secreting adenomas (64.3%), 6 of 6 TSH-secreting adenomas (100%), 2 of 5 ACTH-secreting adenomas (40%) and 9 of 19 nonfunctioning adenomas (47.4%) including immunohistochemically gonadotropin-subunit-positive adenomas. The colocalization of RXR gamma with the TSH beta subunit, GH and alpha SU in the same adenoma cells was frequently observed, and sometimes RXR gamma was colocalized with PRL, ACTH, FSH beta or LH beta as shown by double immunostaining. We conclude that RXR alpha is expressed in both human pituitaries and pituitary adenomas. In contrast, RXR gamma is expressed more broadly in pituitary adenomas than in normal pituitaries and thus may play a role in the differentiation-specific cell types in the human pituitary both under physiological and pathological conditions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9143002     DOI: 10.1159/000127188

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  7 in total

Review 1.  Pit-1 positive alpha-subunit positive nonfunctioning human pituitary adenomas: a dedifferentiated GH cell lineage?

Authors:  R Y Osamura; S Tahara; K Komatsubara; Y Itoh; H Kajiwara; R Kurotani; N Sanno; A Teramoto
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

2.  Expression of Ptx1 in the adult rat pituitary glands and pituitary cell lines: hormone-secreting cells and folliculo-stellate cells.

Authors:  R Kurotani; S Tahara; N Sanno; A Teramoto; P L Mellon; K Inoue; S Yoshimura; R Y Osamura
Journal:  Cell Tissue Res       Date:  1999-10       Impact factor: 5.249

3.  Thyroid hormone resistance and increased metabolic rate in the RXR-gamma-deficient mouse.

Authors:  N S Brown; A Smart; V Sharma; M L Brinkmeier; L Greenlee; S A Camper; D R Jensen; R H Eckel; W Krezel; P Chambon; B R Haugen
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

4.  Retinoid X receptor mRNA expression in human pituitary gland.

Authors:  C Segura; M Alonso; R Pérez-Fernández
Journal:  J Physiol Biochem       Date:  2000-06       Impact factor: 4.158

Review 5.  New Insights in Cushing Disease Treatment With Focus on a Derivative of Vitamin A.

Authors:  Mariana Fuertes; Julieta Tkatch; Josefina Rosmino; Leandro Nieto; Mirtha Adriana Guitelman; Eduardo Arzt
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-24       Impact factor: 5.555

6.  Integrated multi-omics profiling of nonfunctioning pituitary adenomas.

Authors:  Zhenqing Wei; Cuiqi Zhou; Minghui Li; Ruocheng Huang; Hongjuan Deng; Stephen Shen; Renzhi Wang
Journal:  Pituitary       Date:  2020-11-18       Impact factor: 4.107

7.  The Role of Isotretinoin Therapy for Cushing's Disease: Results of a Prospective Study.

Authors:  Lucio Vilar; José Luciano Albuquerque; Ruy Lyra; Erik Trovão Diniz; Frederico Rangel Filho; Patrícia Gadelha; Ana Carolina Thé; George Robson Ibiapina; Barbara Sales Gomes; Vera Santos; Maíra Melo da Fonseca; Karoline Frasão Viana; Isis Gabriella Lopes; Douglas Araújo; Luciana Naves
Journal:  Int J Endocrinol       Date:  2016-02-29       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.